Monique Marelis

Keine laufenden Positionen mehr

Consumer Services

Commercial Services

Profil

Monique Marelis worked as the Director of Human Resources at Amsterdam Molecular Therapeutics (AMT) Holding NV from 2010 to 2013.
Prior to that, she worked as a Manager of Human Resources at Dell BV.
She holds a Master's degree in Business Administration from Kingston University.

Ehemalige bekannte Positionen von Monique Marelis

Unternehmen	Position	Ende
Amsterdam Molecular Therapeutics (AMT) Holding NV Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands.	Personalreferent	11.03.2013
Dell BV	Personalreferent	-

Sehen Sie sich die Erfahrung von Monique Marelis im Detail an

Ausbildung von Monique Marelis

Kingston University

Masters Business Admin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Monique Marelis im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
Amsterdam Molecular Therapeutics (AMT) Holding NV Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands.	Commercial Services
Dell BV